177 related articles for article (PubMed ID: 31030942)
21. Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells.
Aguado A; Fischer T; Rodríguez C; Manea A; Martínez-González J; Touyz RM; Hernanz R; Alonso MJ; Dixon DA; Briones AM; Salaices M
J Hypertens; 2016 Feb; 34(2):253-65. PubMed ID: 26682942
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells.
He M; Han M; Zheng B; Shu YN; Wen JK
J Biochem; 2009 Nov; 146(5):683-91. PubMed ID: 19628677
[TBL] [Abstract][Full Text] [Related]
23. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
Touyz RM; Chen X; Tabet F; Yao G; He G; Quinn MT; Pagano PJ; Schiffrin EL
Circ Res; 2002 Jun; 90(11):1205-13. PubMed ID: 12065324
[TBL] [Abstract][Full Text] [Related]
24. Elongation of Long-Chain Fatty Acid Family Member 6 (Elovl6)-Driven Fatty Acid Metabolism Regulates Vascular Smooth Muscle Cell Phenotype Through AMP-Activated Protein Kinase/Krüppel-Like Factor 4 (AMPK/KLF4) Signaling.
Sunaga H; Matsui H; Anjo S; Syamsunarno MR; Koitabashi N; Iso T; Matsuzaka T; Shimano H; Yokoyama T; Kurabayashi M
J Am Heart Assoc; 2016 Nov; 5(12):. PubMed ID: 27881420
[TBL] [Abstract][Full Text] [Related]
25. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM
Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342
[TBL] [Abstract][Full Text] [Related]
26. Sauchinone inhibits angiotensin II-induced proliferation and migration of vascular smooth muscle cells.
Wang Y; Li X; Huang X; Ma S; Xing Y; Geng X; He X
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):220-226. PubMed ID: 31587339
[TBL] [Abstract][Full Text] [Related]
27. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
He X; Deng J; Yu XJ; Yang S; Yang Y; Zang WJ
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2649-2664. PubMed ID: 32938216
[TBL] [Abstract][Full Text] [Related]
28. KLF4 prevented angiotensin II-induced smooth muscle cell senescence by enhancing autophagic activity.
Xu H; Yu M; Yu Y; Li Y; Yang F; Liu Y; Han L; Xu Z; Wang G
Eur J Clin Invest; 2022 Sep; 52(9):e13804. PubMed ID: 35506324
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effects of 6'-sialyllactose on angiotensin II-induced proliferation, migration, and osteogenic switching in vascular smooth muscle cells.
Nguyen TLL; Jin Y; Kim L; Heo KS
Arch Pharm Res; 2022 Sep; 45(9):658-670. PubMed ID: 36070173
[TBL] [Abstract][Full Text] [Related]
30. S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2.
Shaw SS; Schmidt AM; Banes AK; Wang X; Stern DM; Marrero MB
Diabetes; 2003 Sep; 52(9):2381-8. PubMed ID: 12941779
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo.
Garvey SM; Sinden DS; Schoppee Bortz PD; Wamhoff BR
J Pharmacol Exp Ther; 2010 Apr; 333(1):34-42. PubMed ID: 20089806
[TBL] [Abstract][Full Text] [Related]
32. Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertension.
Camargo LL; Montezano AC; Hussain M; Wang Y; Zou Z; Rios FJ; Neves KB; Alves-Lopes R; Awan FR; Guzik TJ; Jensen T; Hartley RC; Touyz RM
Cardiovasc Res; 2022 Mar; 118(5):1359-1373. PubMed ID: 34320175
[TBL] [Abstract][Full Text] [Related]
33. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway.
Zhang M; Li F; Wang X; Gong J; Xian Y; Wang G; Zheng Z; Shang C; Wang B; He Y; Wang W; Lin R
Histochem Cell Biol; 2020 May; 153(5):357-366. PubMed ID: 32124010
[TBL] [Abstract][Full Text] [Related]
34. B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
Hsu JH; Liou SF; Yang SN; Wu BN; Dai ZK; Chen IJ; Yeh JL; Wu JR
Pediatr Pulmonol; 2014 Aug; 49(8):734-44. PubMed ID: 24167111
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
[TBL] [Abstract][Full Text] [Related]
36. The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation.
Bourmoum M; Charles R; Claing A
PLoS One; 2016; 11(1):e0148097. PubMed ID: 26824355
[TBL] [Abstract][Full Text] [Related]
37. CX3CL1/CX3CR1 Axis Contributes to Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation and Inflammatory Cytokine Production.
Li C; He J; Zhong X; Gan H; Xia Y
Inflammation; 2018 Jun; 41(3):824-834. PubMed ID: 29356931
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of reinioside C on vascular smooth muscle cells proliferation induced by angiotensin II via inhibiting NADPH oxidase-ROS-ENK1/2-NF-kappaB-AP-1 pathway.
Hong D; Bai YP; Shi RZ; Tan GS; Hu CP; Zhang GG
Pharmazie; 2014 Sep; 69(9):698-703. PubMed ID: 25272943
[TBL] [Abstract][Full Text] [Related]
39. L-Theanine Down-Regulates the JAK/STAT3 Pathway to Attenuate the Proliferation and Migration of Vascular Smooth Muscle Cells Induced by Angiotensin II.
Ben P; Hu M; Wu H; Zhang Z; Gao Y; Luo L; Yin Z
Biol Pharm Bull; 2018; 41(11):1678-1684. PubMed ID: 30381668
[TBL] [Abstract][Full Text] [Related]
40. Role of p22phox in angiotensin II and platelet-derived growth factor AA induced activator protein 1 activation in vascular smooth muscle cells.
Viedt C; Fei J; Krieger-Brauer HI; Brandes RP; Teupser D; Kamimura M; Katus HA; Kreuzer J
J Mol Med (Berl); 2004 Jan; 82(1):31-8. PubMed ID: 14652666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
